We’ve achieved major milestones in environmental sustainability, reducing our impacts on the planet and demonstrating progress against our ESG goals: ✔️ Validation by the Science Based Targets initiative (SBTi) for our near-term and net-zero environment targets ✔️ Honored with the 2024 ENERGY STAR Partner of the Year: Sustained Excellence award ✔️ Earned USGBC’s LEED Platinum certification for our state-of-the-art research facility in Cambridge, Massachusetts ✔️ Named to Dow Jones Sustainability Index North America Learn more about our progress: bit.ly/3SiXCFx #Sustainability #EnvironmentalStewardship #SBTi
关于我们
百时美施贵宝是一家领先的生物制药企业,公司的使命是研发并提供创新和高质量的药物,帮助患者战胜严重疾病。我们专注于肿瘤、心血管、免疫学和纤维化等疾病领域帮助全球各地的无数患者。依托我们的研发组织,我们建立了一条潜在治疗方法的研发线,并且积极开展合作,借助外部创新拓展和加快推进我们的工作。 百时美施贵宝致力于满足中国未被满足的迫切的重大疾病需求,重点关注病毒性肝炎和免疫肿瘤两大疾病领域,引领行业发展,开展多元合作,加速提供创新的生物制药产品,以帮助中国患者战胜严重疾病。 为患者服务——这是我们一切行为的动力!
- 网站
-
http://www.bms.com
百时美施贵宝的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Lawrence Township,NJ
- 类型
- 上市公司
- 领域
- biotechnology、innovation、great place to work、pharmaceuticals、research and development和healthcare
地点
百时美施贵宝员工
-
Bill Trebasky
Biopharmaceuticals Operations Executive
-
Mark Kaplan
Senior Director Translational Oncology
-
Lisa Filaferro, MBA, PHR
-
Lakshman Nagesh Yerramalla
Transformations Strategist, Sr. PMO Leader - Expert in envisioning and driving transformational initiatives, Strategy execution, Building…
动态
-
We’re honored to be recognized as one of the 2024 Best Places to Work for Disability Inclusion, earning 100 on the Disability:IN Disability Equality Index® (DEI). This #DisabilityPrideMonth, learn how our Disability Advancement Workplace Network (DAWN) People Business and Resource Group fosters our culture of inclusion where our colleagues with disabilities are valued and respected: https://bit.ly/4d5yY37 #DEI24
-
百时美施贵宝转发了
As PRIDE month comes to a close, I’d like to reflect on the incredible sense of community and support I witnessed throughout June. Our journey began with a powerful flag-raising ceremony that set the tone for a month of unity and inclusivity. We marched with joy and solidarity in the PRIDE parade, showcasing our unwavering support for LGBTQ+ rights. Our patient panel provided invaluable insights and fostered deep, meaningful conversations about the experiences and challenges faced by LGBTQ+ individuals. And finally, our delightful Drag Queen Charity Bingo event brought us all together for an afternoon of fun, laughter, and fundraising for vital LGBTQ+ charities. None of this would be possible without the hard work of our Bristol Myers Squibb PRIDE Alliance team, who turns our values into real-life actions that make an impact. Thank you to everyone who participated, supported, and celebrated with us this month. Together, we continue to build a more inclusive and compassionate community, both within our organization and beyond. #BMSemployee
-
We have been recognized by S&P Global’s Dow Jones Sustainability Index North America as a corporate sustainability industry leader. This accomplishment reflects our commitment to continuously improving our environmental, social and governance practices to creating a sustainable around the world. Learn more about our commitment to operating responsibly: https://bit.ly/3W1c5Ip #DJSI #sustainability #ESG
-
Sixty of our colleagues in Australia, China, Japan, Korea, Taiwan and the United States begin their #C2C4C Japan fundraising this month, culminating in an epic bike ride this October. Learn about their journey as they raise funds for CancerNet Japan to advance cancer research for patients. See more: https://bit.ly/4cjOw3o
-
We’ve advanced LGBTQIA+ inclusion in over a dozen U.S. clinical trials since last year by implementing orientation, gender identity, and intersex status (SOGIIS) data. This #PrideMonth, learn about our efforts to do more across the industry to expand clinical trial diversity while respecting patients’ privacy: https://bit.ly/4cjtkuf
-
百时美施贵宝转发了
The Economist Impact has just released a report commissioned by Bristol Myers Squibb (BMS) on how to address the undertreatment and unmet needs of #psoriasis patients. If you missed the discussion with Prof Jo Lambert, Frida Dunger, Executive Director of IFPA, and Leah Howard, J.D., President and CEO of National Psoriasis Foundation access the online recording from #IFPAConference2024 and read the report here. https://lnkd.in/d4RJsvsB
-
We are thrilled to announce that Francisco Ramírez-Valle, MD, PhD, FAAD, our Senior Vice President and Head of the Immunology and Cardiovascular Thematic Research Center, has been recognized in Endpoints News' annual feature on LGBTQ+ leaders in biopharma! Francisco's leadership and dedication to advancing scientific research while fostering an inclusive environment exemplify our core values at Bristol Myers Squibb. His contributions are not only shaping the future of the immunology and cardiovascular treatment landscape but also paving the way for greater LGBTQ+ representation in clinical trials and the biotech industry overall. “If I can be a mentor to anyone, whether they’re a Latino kid...or from a sexual minority, that they can achieve everything that they want and become a leader if that’s what they want, that would be amazing,” he said. While we celebrate Francisco and the other incredible honorees, we must acknowledge the challenges the LGBTQ+ community continues to face. Francisco's recognition is a testament to the progress we've made and the work that still needs to be done. Join us in celebrating Francisco and the inspiring work of all the honorees. #LGBTQLeadership #SOGIIS #HealthEquity Read more: https://bit.ly/3ztX354
-
Our team is consistently pursuing innovative research and solutions to help people living with immune-mediated diseases like #UlcerativeColitis find relief. Learn more about an exciting new analysis of our Phase 3 trial evaluating a treatment for adults with moderately-to-severely active ulcerative colitis. Read more in the journal Clinical Gastroenterology and Hepatology. https://bit.ly/4eA8qIP